EMA
safety_alert
· 2017-07-07
EMA restricts use of multiple sclerosis medicine Zinbryta
Summary
EMA restricts the use of Zinbryta after reports of serious brain inflammation and immune-related conditions; only patients who already benefit and where other t…
Upgrade for the full analysis, importance score, and drug timeline.